{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:23:45Z","timestamp":1791566625208,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4158\/ep14195.or","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T21:59:07Z","timestamp":1407880747000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Normocalcemic Hyperparathyroidism and Insulin Resistance"],"prefix":"10.1016","volume":"21","author":[{"given":"Sule","family":"Temizkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Kocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadriye","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysenur","family":"Ozderya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulgun","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Sargin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP14195.OR_bb0005","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"\u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14195.OR_bb0010","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14195.OR_bb0015","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/jc.2004-1891","article-title":"Association between primary hyperparathyroidism and increased body weight: a meta-analysis","volume":"90","author":"Bolland","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14195.OR_bb0020","first-page":"548","article-title":"Prevalence of cardiovascular risk factors in male and female patients with primary hyper-parathyroidism","volume":"35","author":"Han","year":"2012","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP14195.OR_bb0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","article-title":"A record linkage study of outcomes in patients with mild primary hyperparathyroid-ism: the Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"75","author":"Yu","year":"2011","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14195.OR_bb0030","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1172\/JCI106760","article-title":"Plasma insulin disturbances in primary hyperparathyroidism","volume":"50","author":"Kim","year":"1971","journal-title":"J Clin Invest."},{"key":"10.4158\/EP14195.OR_bb0035","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0026-0495(83)90110-5","article-title":"Peripheral insulin resistance in primary hyperparathyroidism","volume":"32","author":"Prager","year":"1983","journal-title":"Metabolism."},{"key":"10.4158\/EP14195.OR_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2265.1994.tb02442.x","article-title":"Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism","volume":"40","author":"Kumar","year":"1994","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14195.OR_bb0045","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/meta.2000.17708","article-title":"Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level","volume":"49","author":"Chiu","year":"2000","journal-title":"Metabolism."},{"key":"10.4158\/EP14195.OR_bb0050","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1464-5491.2002.00809.x","article-title":"The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mel-litus in primary hyperparathyroidism","volume":"19","author":"Procopio","year":"2002","journal-title":"Diabet Med."},{"key":"10.4158\/EP14195.OR_bb0055","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1464-5491.2009.02804.x","article-title":"Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism","volume":"26","author":"Tassone","year":"2009","journal-title":"Diabet Med."},{"key":"10.4158\/EP14195.OR_bb0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/dmrr.199","article-title":"Coincident diabetes mellitus and primary hyperparathyroidism","volume":"17","author":"Taylor","year":"2001","journal-title":"Diabetes Metab Res Rev."},{"key":"10.4158\/EP14195.OR_bb0065","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.ejcn.1602375","article-title":"Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects","volume":"60","author":"Haap","year":"2006","journal-title":"Eur J Clin Nutr."},{"key":"10.4158\/EP14195.OR_bb0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00125-006-0532-9","article-title":"Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinae-mic clamp in a community-based cohort","volume":"50","author":"Hagstr\u00f6m","year":"2007","journal-title":"Diabetologia."},{"key":"10.4158\/EP14195.OR_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","article-title":"Normocalcemic primary hyperparathyroidism","volume":"16","author":"Cusano","year":"2013","journal-title":"J Clin Densitom."},{"key":"10.4158\/EP14195.OR_bb0080","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.surg.2012.08.013","article-title":"Calculating an individual maxPTH to aid diagnosis of normocalemic primary hyperparathyroidism","volume":"152","author":"Jin","year":"2012","journal-title":"Surgery."},{"key":"10.4158\/EP14195.OR_bb0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4158\/EP10389.OR","article-title":"A new, vitamin D-based, multidimensional nomogram for the diagnosis of primary hyperparathyroidism","volume":"18","author":"Harvey","year":"2012","journal-title":"Endocr Pract."},{"key":"10.4158\/EP14195.OR_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMcp1009570","article-title":"Clinical practice. Vitamin D insufficiency","volume":"364","author":"Rosen","year":"2011","journal-title":"N Engl J Med."},{"key":"10.4158\/EP14195.OR_bb0095","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care."},{"key":"10.4158\/EP14195.OR_bb0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia."},{"issue":"Suppl 1","key":"10.4158\/EP14195.OR_bb0105","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.2337\/dc13-S067","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14195.OR_bb0110","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","article-title":"Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism","volume":"26","author":"Ascaso","year":"2003","journal-title":"Diabetes Care."},{"key":"10.4158\/EP14195.OR_bb0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12020-012-9627-x","article-title":"Investigation of insulin resistance in patients with normocalcemic primary hyperpara-thyroidism","volume":"42","author":"Cakir","year":"2012","journal-title":"Endocrine."},{"key":"10.4158\/EP14195.OR_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02173","article-title":"Metabolic abnormalities in patients with normocalce-mic hyperparathyroidism detected at a population-based screening","volume":"155","author":"Hagstr\u00f6m","year":"2006","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14195.OR_bb0125","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1210\/endo-125-5-2341","article-title":"Mechanism of insulin resistance induced by sustained levels of cyto-solic free calcium in rat adipocytes","volume":"125","author":"Draznin","year":"1989","journal-title":"Endocrinology."},{"key":"10.4158\/EP14195.OR_bb0130","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2337\/diacare.27.12.2813","article-title":"Bell C; Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvi-tamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey","volume":"27","author":"Scragg","year":"2004","journal-title":"Diabetes Care."},{"key":"10.4158\/EP14195.OR_bb0135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF03347410","article-title":"Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity","volume":"30","author":"Kamycheva","year":"2007","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP14195.OR_bb0140","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ajcn\/79.5.820","article-title":"Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction","volume":"79","author":"Chiu","year":"2004","journal-title":"Am J Clin Nutr."},{"key":"10.4158\/EP14195.OR_bb0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.metabol.2007.08.023","article-title":"Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season","volume":"57","author":"Alemzadeh","year":"2008","journal-title":"Metabolism."},{"key":"10.4158\/EP14195.OR_bb0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3945\/jn.108.093831","article-title":"Plasma 25-hydroxyvi-tamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults","volume":"139","author":"Liu","year":"2009","journal-title":"J Nutr."},{"key":"10.4158\/EP14195.OR_bb0155","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2337\/dc09-0209","article-title":"Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals","volume":"32","author":"Lu","year":"2009","journal-title":"Diabetes Care."},{"key":"10.4158\/EP14195.OR_bb0160","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2337\/dc09-2199","article-title":"Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans","volume":"33","author":"Pinelli","year":"2010","journal-title":"Diabetes Care."},{"key":"10.4158\/EP14195.OR_bb0165","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2337\/db11-0465","article-title":"Prospective associations of vitamin D with b-cell function and glyce-mia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study","volume":"60","author":"Kayaniyil","year":"2011","journal-title":"Diabetes."},{"key":"10.4158\/EP14195.OR_bb0170","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/aps.2013.13","article-title":"Association of serum 25-hydroxyvitamin D with insulin resistance and b-cell function in a healthy Chinese female population","volume":"34","author":"Tao","year":"2013","journal-title":"Acta Pharmacol Sin."},{"key":"10.4158\/EP14195.OR_bb0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3945\/jn.110.129619","article-title":"is not associated with insulin resistance or beta cell function in Canadian Cree","volume":"141","author":"Del Gobbo","year":"2011","journal-title":"J Nutr."},{"key":"10.4158\/EP14195.OR_bb0180","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2337\/dc09-1692","article-title":"Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome","volume":"33","author":"Gulseth","year":"2010","journal-title":"Diabetes Care."},{"key":"10.4158\/EP14195.OR_bb0185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0960-0760(03)00032-3","article-title":"Identification of a Vitamin D response element in the human insulin receptor gene promoter","volume":"84","author":"Maestro","year":"2003","journal-title":"J Steroid Biochem Mol Biol."},{"key":"10.4158\/EP14195.OR_bb0190","first-page":"11","article-title":"D-hormone and the immune system","volume":"76","author":"Cantorna","year":"2005","journal-title":"J Rheumatol Suppl."},{"key":"10.4158\/EP14195.OR_bb0195","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology."},{"key":"10.4158\/EP14195.OR_bb0200","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1210\/jc.2011-2280","article-title":"Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity","volume":"97","author":"Grethen","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14195.OR_bb0205","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-118-5-199303010-00003","article-title":"Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Assessment by use of biochemical markers","volume":"118","author":"Cosman","year":"1993","journal-title":"Ann Intern Med."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20433427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20433427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/DV61222768376379.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:59:43Z","timestamp":1761515983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20433427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"alternative-id":["S1530891X20433427"],"URL":"https:\/\/doi.org\/10.4158\/ep14195.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normocalcemic Hyperparathyroidism and Insulin Resistance","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP14195.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}